Related Experiment Videos
Expression of angiostatin using DNA-based semliki forest virus replicon
Yong-Soo Choi1, Jong-Soo Lee, Young-Ki Choi
1College of Veterinary Medicine, Chungnam National University, Daejon, 305-764, Korea.
Journal of Veterinary Science
|November 14, 2003
Summary
Researchers developed a DNA vector to express angiostatin, an anti-cancer protein that inhibits tumor growth and metastasis by blocking new blood vessel formation.
Area of Science:
- Molecular Biology
- Oncology
- Biotechnology
Background:
- Angiogenesis is crucial for tumor growth and metastasis.
- Anti-angiogenic substances, like angiostatin, show promise in cancer therapy.
- Angiostatin, derived from plasminogen, inhibits tumor neovascularization and promotes apoptosis.
Purpose of the Study:
- To construct a DNA-based Semliki Forest Virus (SFV) replicon vector for expressing angiostatin.
- To facilitate efficient gene delivery and protein expression for anti-angiogenesis research.
- To enable the detection and secretion of functional angiostatin.
Main Methods:
- Construction of an SFV-derived DNA vector using the CMV promoter.
- Inclusion of C-myc epitope and polyhistidine tags for protein detection.
- Addition of a murine Ig k-chain signal sequence for protein secretion.
- Transfection of BHK-21 cells with the DNA-based SFV replicon.
Main Results:
- Successful construction of a DNA-based SFV replicon vector.
- Confirmed expression of angiostatin in BHK-21 cells.
- Demonstrated the feasibility of using this vector for producing anti-angiogenic proteins.
Conclusions:
- The developed DNA-based SFV replicon system enables efficient expression and secretion of angiostatin.
- This system provides a valuable tool for studying anti-angiogenic therapies.
- Further research can utilize this vector for developing novel cancer treatments.